A recent study found that METTL3 is significantly upregulated in BLCA tissues and that patients with high expression of METTL3 had a worse prognosis and shorter overall survival compared to those with low expression of METTL3 (Figure 2) [83]. The gene discussed is METTL3; the disease is bladder transitional cell carcinoma.